The results demonstrated that CCR6 promotes breast cancer initiation and progression through maintenance of pro-tumorigenic TAMs within tumor-bearing mammary glands, warranting further investigation of CCR6 as a possible therapeutic target. This evidence concerns the gene CCR6 and neoplasm.